OncoSenX logo

OncoSenX

oncosenx.com

OncoSenX develops targeted cancer therapies that use a proteo-lipid vehicle to deliver plasmid DNA, inducing apoptosis in cancer cells based on their transcriptional activity. Its approach aims to precisely target solid tumors while minimizing side effects and avoiding harm to healthy cells.

Facts

HQ
Seattle, Washington
Sectors
Biotechnology, Therapeutics, Oncology
Stage
Seed
Members see funding amounts.
.

Is this your organization? Claim it

Recent coverage

Front-page news, podcasts and videos about OncoSenX

People

  • Eric Garcia Executive, Chief Operating Officer
  • Matthew Scholz Executive, Chief Executive Officer
  • Stephen Hilbert Executive, Chief Business Officer

Online

Questions about OncoSenX

What is OncoSenX?

OncoSenX is a startup based in Seattle, Washington that develops targeted cancer therapies using a proteo-lipid vehicle to deliver plasmid DNA and induce cancer-cell death based on transcriptional activity.

What has OncoSenX been in the news for?

GeekWire reported in May 2020 on OncoSenX's plans for Phase I development of genetics-targeted cancer therapies. In July 2019, GeekWire reported on OncoSenX's work to advance non-viral, gene-delivery cancer therapeutics targeting solid tumors.

Who are the people behind OncoSenX?

Matthew Scholz is chief executive officer of OncoSenX, Eric Garcia is chief operating officer, and Stephen Hilbert is chief business officer.

Who invested in OncoSenX, and how much has it raised?

Members of Seattle Flow see OncoSenX's funding rounds, amounts and investors on its Funding tab. Joining is free.

Where is OncoSenX based?

OncoSenX is based in Seattle, Washington.